Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 2+2=5

"It looks to me like each of them can now hold up to 9.99% of the co. share"

I read the SEC filing carefully on this and S&L are treated as one entitiy.I thought this question was previouly resolved.

Share
New Message
Please login to post a reply